Arbor partners with Chiesi Group in gene editing dealnews2025-10-06T11:00:11+00:00October 6th, 2025|Endpoints News|
Gene therapy startup launches with $11M to tackle aging disease of the eyenews2025-10-02T11:00:20+00:00October 2nd, 2025|Endpoints News|
Galapagos says it’s weeks away from decision on cell therapy business reviewnews2025-10-02T01:59:11+00:00October 2nd, 2025|Endpoints News|
Opus says gene therapy for ultra-rare disease boosted vision in teensnews2025-09-30T11:00:13+00:00September 30th, 2025|Endpoints News|
Patient groups push abandoned rare disease gene therapy toward clinical trialnews2025-09-26T14:32:48+00:00September 26th, 2025|Endpoints News|
Biogen calls it quits on AAV gene therapy, againnews2025-09-25T18:33:19+00:00September 25th, 2025|Endpoints News|
FDA unveils trio of new draft guidances to help cell and gene therapy developersnews2025-09-24T17:30:04+00:00September 24th, 2025|Endpoints News|
With successful trial, uniQure eyes 2026 launch for Huntington’s gene therapynews2025-09-24T11:26:50+00:00September 24th, 2025|Endpoints News|
Aera Therapeutics jumps into in vivo CAR-T race with trial planned for 2026news2025-09-23T18:00:33+00:00September 23rd, 2025|Endpoints News|
